March 10, 1992
Biopool International Inc., a Ventura company that makes blood diagnostic test kits and other blood-related products, said it acquired Medical Diagnostic Technologies Inc. in a stock swap valued at about $1.75 million. Medical Diagnostic, based in Ventura, also makes blood diagnostic test kits. Biopool said the acquisition would broaden its product offerings, about one-third of which have received market approval from the U.S. Food and Drug Administration.
July 25, 1995
Biopool International Inc., a Ventura producer of medical test kits, said it has developed a new test that would pinpoint people at risk for heart attacks and strokes. The test was presented at a research conference in Israel last month, and focuses on blood platelets. Using the new test, researchers mix the antibodies of chickens with human blood platelets for analysis. The results screen out those at high risk of cardiovascular ailments.
June 8, 1993
Biopool International Inc., a Ventura maker of blood-disorder diagnostic kits, said it completed a private placement of 1.17 million shares of its unregistered common stock. The stock was purchased by International Capital Partners Inc. of Stamford, Conn. and VK Capital Co. of San Francisco for $1.875 a share, or a total of about $2.2 million.
May 18, 1993
Biopool International Inc., which makes test kits for diagnosing blood disorders, reported a 36% drop in earnings in the first quarter. The Ventura company said its profit in the three months ended March 31 was $78,349, down from net income of $121,496 a year before. Its revenue fell 13%, to $1.03 million from $1.18 million. Biopool said the results reflected lower sales from its Swedish subsidiary because of the decline in the value of the Swedish currency compared to the dollar.
November 3, 1992 |
Biopool International Inc., a Ventura firm that produces medical diagnostic kits, has received approval from the Food and Drug Administration to market two new kits. The first, called the Minutex D-Dimer, tests patients for deep-vein thrombosis or blood clots, said Michael D. Bick, Biopool's chief executive. He said the kit is less costly and takes less time than other tests now being used.
April 14, 1992 |
Biopool International Inc. of Ventura received approval from Mexico's Ministry of Health for the sale in that country of Biopool's blood diagnostic test kits. Dr. Michael Bick, Biopool's chief executive officer, declined to estimate how much the approval will add to his company's sales, but said, "We certainly think Mexico will become a major market for us." Biopool manufactures about 30 diagnostic kits used by hospitals and labs worldwide to test for blood and heart disorders.